New Antibody Treatment for HIV Passes First Hurdle

An experimental treatment providing a new approach in the fight against HIV has cleared the first hurdle. VRC01 is a so-called monoclonal antibody, a relatively recent development in the arsenal of bioengineered therapies. Monoclonal antibodies are similar to the antibodies produced by the human immune system, which are proteins that go after and destroy disease-causing organisms. But monoclonal drugs contain antibodies explicitly engineered by scientists to target a specific...

© La Voix de l'Amérique - mercredi 23 décembre 2015